期刊文献+
共找到2,276篇文章
< 1 2 114 >
每页显示 20 50 100
Philippine retinoblastoma initiative multi-eye center study 2010-2020
1
作者 Roland Joseph D.Tan Gary John V.Mercado +26 位作者 Patricia E.Cabrera Paulita Pamela P.Astudillo Rolando Enrique D.Domingo Josept Mari S.Poblete Charmaine Grace M.Cabebe Adriel Vincent R.Te Melissa Anne S.Gonzales Jocelyn G.Sy Beltran Alexis A.Aclan Jayson T.So Fatima G.Regala Kimberley Amanda K.Comia Josemaria M.Castro Mara Augustine S.Galang Aldous Dominic C.Cabanlas Benedicto Juan E.Aguilar Gabrielle S.Evangelista Jo Michael Maniwan Andrei P.Martin Calvin Y.Martinez John Alfred H.Lim Rena Ivy Bascuna Rachel M.Ng Kevin B.Agsaoay Kris Zanna A.Acluba-Arao Ellaine Rose V.Apostol Beatriz M.Prieto 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2024年第1期144-156,共13页
AIM:To provide a comprehensive and more representative national data on the disease,especially on treatment options and outcomes,and to determine access of retinoblastoma patients from Luzon,Visayas and Mindanao to ey... AIM:To provide a comprehensive and more representative national data on the disease,especially on treatment options and outcomes,and to determine access of retinoblastoma patients from Luzon,Visayas and Mindanao to eye care,and determine if access is associated with delay in consultation,staging and outcomes.METHODS:Cohort study of retinoblastoma patients seen in eleven institutions located in the three major areas of the Philippines namely Luzon,Vizayas and Mindanao from 2010-2020.RESULTS:Totally 636 patients,involving 821 eyes,were included.Majority(57%)were from Luzon and were seen in institutions in Luzon(72%).Annually,58±10 new cases were seen with 71%having unilateral disease.Median delay of consultation remained long at 9(3,17)mo,longest in patients with unilateral disease(P<0.02)and those from the Visayas(P<0.003).Based on the International Retinoblastoma Staging System,only 35%of patients had Stage 1 while 47%already had extraocular disease.Enucleation was the most common treatment received by 484 patients while intravenous chemotherapy was received by 469.There were 250(39%)patients alive,195(31%)dead,85(13%)abandoned,17(3%)refused and 89(14%)with no data.CONCLUSION:This study presents the largest cohort of retinoblastoma patients in the Philippines in terms of patients’and participating institutions’number and geographical location and type of institution(private and public).It also presents more comprehensive data on the treatments used and outcomes(survival,globe salvage,and vision retention rates).Delay in consultation was still long among patients leading to advanced disease stage and lower survival rate.Despite increasing capacity to diagnose and manage retinoblastoma in the country,the delay of consultation remains long primarily due to accessibility issues to eye care institutions especially in the Visayas and financial concerns.The delay was still significant that overall survival rate remain low. 展开更多
关键词 retinoblastoma Philippines clinical profile
下载PDF
Prox1 Suppresses Proliferation and Drug Resistance of Retinoblastoma Cells via Targeting Notch1
2
作者 Hong-li ZHANG Na LI +2 位作者 Lin DONG Hong-xia MA Mo-chi YANG 《Current Medical Science》 SCIE CAS 2024年第1期223-231,共9页
Objective Retinoblastoma(RB)is a prevalent type of eye cancer in youngsters.Prospero homeobox 1(Prox1)is a homeobox transcriptional repressor and downstream target of the proneural gene that is relevant in lymphatic,h... Objective Retinoblastoma(RB)is a prevalent type of eye cancer in youngsters.Prospero homeobox 1(Prox1)is a homeobox transcriptional repressor and downstream target of the proneural gene that is relevant in lymphatic,hepatocyte,pancreatic,heart,lens,retinal,and cancer cells.The goal of this study was to investigate the role of Prox1 in RB cell proliferation and drug resistance,as well as to explore the underlying Notch1 mechanism.Methods Human RB cell lines(SO-RB50 and Y79)and a primary human retinal microvascular endothelial cell line(ACBRI-181)were used in this study.The expression of Prox1 and Notch1 mRNA and protein in RB cells was detected using quantitative real time-polymerase chain reaction(RT-qPCR)and Western blotting.Cell proliferation was assessed after Prox1 overexpression using the Cell Counting Kit-8 and the MTS assay.Drug-resistant cell lines(SO-RB50/vincristine)were generated and treated with Prox1 to investigate the role of Prox1 in drug resistance.We employed pcDNA-Notch1 to overexpress Notch1 to confirm the role of Notch1 in the protective function of Prox1.Finally,a xenograft model was constructed to assess the effect of Prox1 on RB in vivo.Results Prox1 was significantly downregulated in RB cells.Overexpression of Prox1 effectively decreased RB cell growth while increasing the sensitivity of drug-resistant cells to vincristine.Notch1 was involved in Prox1’s regulatory effects.Notch1 was identified as a target gene of Prox1,which was found to be upregulated in RB cells and repressed by increased Prox1 expression.When pcDNA-Notch1 was transfected,the effect of Prox1 overexpression on RB was removed.Furthermore,by downregulating Notch1,Prox1 overexpression slowed tumor development and increased vincristine sensitivity in vivo.Conclusion These data show that Prox1 decreased RB cell proliferation and drug resistance by targeting Notch1,implying that Prox1 could be a potential therapeutic target for RB. 展开更多
关键词 Proxl NOTCH1 retinoblastoma cells PROLIFERATION drug resistance
下载PDF
Decoding Retinoblastoma: Differential Gene Expression
3
作者 Ahmed Jasim Mahmood Al-Mashhadani Franko Shehaj Lianhong Zhou 《International Journal of Clinical Medicine》 CAS 2024年第4期177-196,共20页
Background: Retinoblastoma, the most common intraocular pediatric cancer, presents complexities in its genetic landscape that necessitate a deeper understanding for improved therapeutic interventions. This study lever... Background: Retinoblastoma, the most common intraocular pediatric cancer, presents complexities in its genetic landscape that necessitate a deeper understanding for improved therapeutic interventions. This study leverages computational tools to dissect the differential gene expression profiles in retinoblastoma. Methods: Employing an in silico approach, we analyzed gene expression data from public repositories by applying rigorous statistical models, including limma and de seq 2, for identifying differentially expressed genes DEGs. Our findings were validated through cross-referencing with independent datasets and existing literature. We further employed functional annotation and pathway analysis to elucidate the biological significance of these DEGs. Results: Our computational analysis confirmed the dysregulation of key retinoblastoma-associated genes. In comparison to normal retinal tissue, RB1 exhibited a 2.5-fold increase in expression (adjusted p Conclusions: Our analysis reinforces the critical genetic alterations known in retinoblastoma and unveils new avenues for research into the disease’s molecular basis. The discovery of chemoresistance markers and immune-related genes opens potential pathways for personalized treatment strategies. The study’s outcomes emphasize the power of in silico analyses in unraveling complex cancer genomics. 展开更多
关键词 retinoblastoma Gene Expression In Silico Study Differentially Expressed Genes CHEMORESISTANCE Immune Response Computational Biology
下载PDF
Epidemiological aspect of retinoblastoma in the world: a review of recent advance studies 被引量:2
4
作者 Leili Koochakzadeh Abbasali Yekta +3 位作者 Hassan Hashemi Reza Pakzad Samira Heydarian Mehdi Khabazkhoob 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2023年第6期962-968,共7页
·AIM: To collect and present updated evidence about epidemiological aspects of retinoblastoma(Rb) in the world.·METHODS: A comprehensive search without the time and language restrictions was conducted in int... ·AIM: To collect and present updated evidence about epidemiological aspects of retinoblastoma(Rb) in the world.·METHODS: A comprehensive search without the time and language restrictions was conducted in international databases, including MEDLINE, Scopus, Web of Science, and Pub Med. The search keywords were “retinoblastoma” OR “retinal Neuroblastoma” OR “retinal glioma” OR “retinoblastoma eye cancer” OR “retinal glioblastoma”.·RESULTS: The worldwide incidence of Rb is 1 in 16 000-28 000 live births, but was higher in developing compared to developed countries. Several attempts for improving early detection and treatment had increased the Rb survival rate from 5% to 90% in developed countries over the past decade, but its survival was lower in developing countries(about 40% in low-income countries) and the majority of mortalities occurred in developing countries. The etiology of Rb could be viewed as genetics in the heritable form and environmental and lifestyle factors in the sporadic form. Some environmental risk factors such as in vitro fertilization;insect sprays;father’s occupational exposure to oil mists in metal working, and poor living conditions might play a role in the occurrence of the disease. Although ethnicity might affect Rb incidence, sex has no documented effect and the best treatment approaches were now ophthalmic artery chemosurgery and intravitreal chemotherapy.·CONCLUSION: Determining the role of genetics and environmental factors helps to accurately predict the prognosis and identify the mechanism of the disease, which can reduce the risk of tumor development. 展开更多
关键词 EPIDEMIOLOGY retinoblastoma LEUKOCORIA children RB1 gene
下载PDF
A delayed diagnosis of unsuspected retinoblastoma in an in vitro fertilisation infant with retinopathy of prematurity 被引量:1
5
作者 Tian Tian Xun-Da Ji +2 位作者 Qi Zhang Jie Peng Pei-Quan Zhao 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2016年第9期1361-1363,共3页
Dear Editor,I am Dr.Tian Tian,from the Department of Ophthalmology,Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,China.I write to present a rare case report of a delayed diag... Dear Editor,I am Dr.Tian Tian,from the Department of Ophthalmology,Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,China.I write to present a rare case report of a delayed diagnosis of unsuspected retinoblastoma(RB)in an in vitro fertilisation(IVF)infant with retinopathy of prematurity. 展开更多
关键词 A delayed diagnosis of unsuspected retinoblastoma in an in vitro fertilisation infant with retinopathy of prematurity
下载PDF
Clinical and genetic characteristics of retinoblastoma patients in a single center with four novel RB1 variants 被引量:1
6
作者 Özge Vural Hatice Tuba Atalay +5 位作者 Gulsum Kayhan Bercin Tarlan Merve Oral Arzu Okur Faruk GüçlüPınarlı Ceyda Karadeniz 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2023年第8期1274-1279,共6页
AIM:To assess the clinical and genetic characteristics of children diagnosed with retinoblastoma(RB)at Gazi University Faculty of Medicine’s Department of Pediatric Oncology.METHODS:All cases diagnosed with RB and re... AIM:To assess the clinical and genetic characteristics of children diagnosed with retinoblastoma(RB)at Gazi University Faculty of Medicine’s Department of Pediatric Oncology.METHODS:All cases diagnosed with RB and received treatment and follow-up in the Ophthalmology and Pediatric Oncology Department,October 2016 to May 2021 were evaluated retrospectively.The RB1 gene was analyzed by next-generation sequencing(NGS)technique in DNAs obtained from peripheral blood samples of the patients.RESULTS:This study included 53 cases with 67 RBaffected eyes during the study period.The mean age was 24.6(median:18.5,range:3–151)mo.There were 15(22.3%)Group D eyes and 39(58.2%)Group E eyes.The RB1 gene was sequenced by the NGS method in 19 patients.Heterozygous RB1:NM_000321.3:c.54_76del(p.Glu19AlafsTer4)variant was detected in a 15-month-old female with bilateral RB.Heterozygous RB1:NM_000321.3:c.1814+3A>T variant was detected in a 5.5-month-old male with bilateral RB.The intronic RB1:NM_000321.3:c.1332+4A>G variant was detected in patient 14,a 13-month-old male with unilateral RB.The RB1:NM_000321.3:c.575_576del(p.Lys192SerfsTer10)variant was found in an 18-month-old female with an allele frequency of 37%.These variants have not been reported in the literature and mutation databases.CONCLUSION:Four novel variants are described and one of them is found in two different patients.This data is crucial for assessing prognosis.It serves as a guide for estimating the long-term risk of secondary malignancy as well as the short-term risk of developing additional malignancies in the same eye and the other eye. 展开更多
关键词 retinoblastoma RB1 novel mutations next generation sequencing
下载PDF
POINTS THAT MERIT CONSIDERATION IN THE DIAGNOSIS OF RETINOBLASTOMA
7
作者 Wenshu Mao Qiaoyun Ma Linghua Zeng Xianghong Lin Youzhao Chen Xinyuan Cao Zuyou Dai Zhongshan Ophthahnic Center Sun Yat-sen University of Medical Sciences Guangzhou, China 《Eye Science》 CAS 1989年第Z1期3-6,共4页
According to the clinical appearances and the characteristics of the onset of 86 Rb cases, some points in the diagnosis merit consideration:1) Since the average symptomatic age was 21.75 months and the mean diagnostic... According to the clinical appearances and the characteristics of the onset of 86 Rb cases, some points in the diagnosis merit consideration:1) Since the average symptomatic age was 21.75 months and the mean diagnostic age was 24.32 months, children under 3 years with leukocoria should be carefully examined, while adult Rb should not be neglected.2) The primary symptom of Rb is mostly leukocoria, but Rb eyes without any symptoms or leukocoria(26 out of 105 eyes in our groups) might also be encountered.3) 4 out of the 86 cases were retinocytoma which is supposed to be a type of Rb degeneration or be.nigh Rh.4) Attention should be paid to abnormalities and second primary tumors in Rb patients.5) The pedigree investigations, twin method and laboratory studies in Rb such as chromosome analysis, EsD, LDH measurement and RFLP technique are useful in the prenatal diagnosis,early diagnosis and the diagnosis of the carriers. 展开更多
关键词 carefully DEGENERATION retinoblastoma CHROMOSOME NEGLECTED mostly supposed children diagnostic DELETION
下载PDF
Epigenetic and Posttranscriptional Regulation in Retinoblastoma
8
作者 Tovar-Hernández Karla Ruíz-Cruz Matilde Marco Antonio Meraz-Ríos 《Advances in Bioscience and Biotechnology》 2023年第4期190-209,共20页
The Retinoblastoma 1 (RB1) gene, located on chromosome 13q14 and encodes the tumor-suppressor retinoblastoma protein, is the cause of Retinoblastoma. The mutational inactivation of both gene alleles brings on this can... The Retinoblastoma 1 (RB1) gene, located on chromosome 13q14 and encodes the tumor-suppressor retinoblastoma protein, is the cause of Retinoblastoma. The mutational inactivation of both gene alleles brings on this cancer. Retinoblastoma (RB) high-risk histopathological characteristics indicate metastasis or local recurrence with rapid progresses following RB1 inactivation. There is growing interest in regulatory activities unconnected to the coding region of the genome, or exome, in addition to epigenetic control mechanisms. The altered epigenome is significant, though by no means the only, problem in the etiology of Retinoblastoma. After all, cancer development is a multistep process in which numerous dissimilar genetic, epigenetic, and posttranscriptional modifications result in a shared phenotype. This study emphasizes the most recent developments in posttranscriptional change and epigenetics related to retinoblastoma tumor biology. Here, we highlight the novel biomarkers the retinoblastoma tumor has expressed to improve patient survival. 展开更多
关键词 retinoblastoma EPIGENETIC ncRNAs MIRNAS lncRNAs circRNAs ceRNAs
下载PDF
番泻苷B通过Wnt/β-catenin通路抑制视网膜母细胞瘤HXO-Rb44细胞增殖、凋亡和侵袭
9
作者 孙蒙蒙 崔博坤 +5 位作者 贾梦 冉柳 王丹荣 冯素婷 张虎 郝建章 《医学分子生物学杂志》 CAS 2024年第2期141-145,153,共6页
目的探究番泻苷B对视网膜母细胞瘤HXO-Rb44细胞增殖、凋亡、侵袭及Wnt/β-catenin信号通路的影响。方法通过采用不同剂量(0、5、10、20μmol/L)番泻苷B处理HXO-Rb44细胞,将细胞随机分为4组:Control组,番泻苷B 5、10、20μmol/L组。MTT... 目的探究番泻苷B对视网膜母细胞瘤HXO-Rb44细胞增殖、凋亡、侵袭及Wnt/β-catenin信号通路的影响。方法通过采用不同剂量(0、5、10、20μmol/L)番泻苷B处理HXO-Rb44细胞,将细胞随机分为4组:Control组,番泻苷B 5、10、20μmol/L组。MTT法检测细胞活力;克隆形成实验检测克隆形成率;流式细胞仪检测细胞凋亡率;Transwell检测侵袭细胞数;细胞成球实验检测细胞成球直径和细胞成球数目;蛋白质印迹检测cleaved caspase-3、caspase-3、MMP-2、MMP-9、SOX2、OCT4、CD44、Wnt1、β-catenin蛋白表达。结果与Control组比较,番泻苷B 10、20μmol/L组细胞活力、克隆形成率显著降低(P<0.05),细胞凋亡率和cleaved caspase-3/caspase-3表达显著升高(P<0.05),侵袭细胞数和MMP-2、MMP-9蛋白表达显著降低(P<0.05),细胞成球直径、细胞成球数目和SOX2、OCT4、CD44蛋白表达显著降低(P<0.05),Wnt1、β-catenin蛋白表达显著降低(P<0.05)。结论番泻苷B可抑制视网膜母细胞瘤HXO-Rb44细胞增殖、侵袭和干细胞样特性,诱导细胞凋亡,抑制Wnt/β-catenin信号通路的活化。 展开更多
关键词 视网膜母细胞瘤 番泻苷B 干细胞样特性 WNT/Β-CATENIN信号通路
下载PDF
Electrophoretic Determination of Aqueous and Serum Neuron-specific Enolase in the Diagnosis of Retinoblastoma
10
作者 Zhongyao Wu, Huasheng Yang, Suhua Pan, Zhicong ChenZhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences , Guangzhou 510060 , China 《眼科学报》 1997年第1期12-16,共5页
Purpose: Neuron-specific enolase (NSE) of containing γ-enolase is considered valuable in the diagnosis of tumours of neuroectodermal origin.Method : We used rapid electrophoretic method on cellulose acetate plate to ... Purpose: Neuron-specific enolase (NSE) of containing γ-enolase is considered valuable in the diagnosis of tumours of neuroectodermal origin.Method : We used rapid electrophoretic method on cellulose acetate plate to determine the pattern of enolase isoenzymes in 21 aqueous humor and 23 serum specimens from retinoblastoma (Rb) and 21 aqueous and 25 serum specimens from 25 control cases to evaluate NSE in the diagnosis of Rb. The assay allowed assessment of all three major isoenzymes (aa,aγ and γγ),and NSE relative activity and its percentage in the total relative activity of the three enolase isoenzymes were assessed by means of fluorometer.Result: Aqueous from all patients with Rb contained aa,ar and rr isoenzymes and presented strong postitive, the positive rate of NSE being 100% and its relative activity accounting for 45 ± 9% of the total relative activity of the 3 enolase isoenzymes; No enolase was detectable in control aqueous with cataract, glaucoma and Coats's diseases (4 cases),but in two 展开更多
关键词 免疫电泳 水状体 血清 成视网膜细胞瘤 神经元性烯醇酶
全文增补中
应用R软件meta4diag程序包实现诊断准确性试验的Meta分析 被引量:6
11
作者 何倩 王晓娜 +3 位作者 喻亚宇 桂裕亮 张超 牛玉明 《中国循证心血管医学杂志》 2016年第2期138-141,共4页
meta4diag程序包是R软件中专用于实现诊断准确性试验(diagnostic test accuracy,DTA)Meta分析的程序包,该程序包基于贝叶斯理论采用INLA(integrated nested Laplace approximation)法来对单个研究效应值进行合并,同时,该程序包还提供了S... meta4diag程序包是R软件中专用于实现诊断准确性试验(diagnostic test accuracy,DTA)Meta分析的程序包,该程序包基于贝叶斯理论采用INLA(integrated nested Laplace approximation)法来对单个研究效应值进行合并,同时,该程序包还提供了SROC(Summary Receiving Operation Characteristic)曲线图的分析与绘制,然而其缺陷在于无法给出异质性检验及风险偏倚评估。本文以实例形式就meta4diag程序包实现诊断准确性试验DTA Meta分析的数据准备与分析、结果汇总及图形绘制等功能作相关简述。 展开更多
关键词 诊断准确性试验 META分析 meta4diag程序包 R软件
下载PDF
基于倾向性评分逆概率加权法的视网膜母细胞瘤疗效评价及其预后影响因素分析
12
作者 石丽娟 李丽 +2 位作者 石福艳 周希彬 吴志鸿 《解放军医学杂志》 CAS CSCD 北大核心 2024年第3期302-307,共6页
目的评估手术、化疗及手术联合化疗3种治疗方式对视网膜母细胞瘤(RB)的疗效,分析RB患者的预后影响因素。方法选取2000年1月1日-2019年12月31日美国监测、流行病学和最终结果(SEER)数据库登记的RB患者1188例临床资料进行回顾性分析。采... 目的评估手术、化疗及手术联合化疗3种治疗方式对视网膜母细胞瘤(RB)的疗效,分析RB患者的预后影响因素。方法选取2000年1月1日-2019年12月31日美国监测、流行病学和最终结果(SEER)数据库登记的RB患者1188例临床资料进行回顾性分析。采用倾向性评分逆概率加权法(IPTW)对接受手术、化疗或手术联合化疗治疗的3组患者基线特征进行平衡。采用Log-rank检验比较3组患者的生存概率,采用Cox回归模型分析RB患者预后影响因素。结果共纳入RB1188例,其中手术组426例,化疗组200例,手术联合化疗组562例。经IPTW加权后,患者的年龄、性别、种族等基线资料均达到平衡(P>0.05)。Log-rank检验结果显示,加权前后3组生存曲线比较差异均有统计学意义(P<0.05);加权后,手术组患者生存情况明显优于化疗组和手术联合化疗组(P<0.05),化疗组与手术联合化疗组比较差异无统计学意义(P>0.05)。加权后患者1年、3年和5年的生存概率为:手术组99.7%、98.9%和98.6%;化疗组97.4%、95.8%和95.8%;手术联合化疗组97.9%、95.8%和95.0%。Cox回归分析结果显示,与手术组比较,化疗组患者特异性死亡风险比为1.367(95%CI 1.100~1.700),手术联合化疗组特异性死亡风险比为1.132(95%CI0.963~1.330);与RB病灶为1个的患者比较,RB病灶数≥2个的患者特异性死亡风险比为0.399(95%CI0.268~0.594)。结论RB患者接受治疗后生存概率较高;在控制年龄、性别等因素的影响后,3种治疗方式中手术的疗效更好;多灶性可能是RB患者预后的独立影响因素。 展开更多
关键词 视网膜母细胞瘤 逆概率加权 疗效 生存分析
下载PDF
婴幼儿视网膜母细胞瘤生存率预测列线图模型的构建
13
作者 苑悦悦 闫磐石 《郑州大学学报(医学版)》 CAS 北大核心 2024年第1期77-82,共6页
目的:构建预测婴幼儿视网膜母细胞瘤(RB)生存率的列线图。方法:收集2004年至2019年SEER数据库中929例RB患儿(0~3岁)的临床资料作为训练集,采用Cox回归分析筛选出婴幼儿RB生存的影响因素,并基于回归结果构建预测RB患儿3、5和10 a生存率... 目的:构建预测婴幼儿视网膜母细胞瘤(RB)生存率的列线图。方法:收集2004年至2019年SEER数据库中929例RB患儿(0~3岁)的临床资料作为训练集,采用Cox回归分析筛选出婴幼儿RB生存的影响因素,并基于回归结果构建预测RB患儿3、5和10 a生存率的列线图。收集2010年至2019年郑州大学第一附属医院诊断的RB患儿111例为外部验证集。利用C指数、ROC曲线、校准曲线和决策曲线分析(DCA)评估列线图模型的预测价值。结果:以因RB死亡为终点事件,Cox回归分析结果显示,肿瘤基底直径≥15 mm、T3期、T4期、M1期和放化疗联合治疗是生存预后的危险因素,HR(95%CI)分别为3.049(1.459~7.782)、6.341(1.811~12.372)、9.554(6.054~13.989)、5.087(1.602~16.155)、10.452(1.180~19.598)。在训练集和外部验证集中,列线图模型预测的C指数(95%CI)分别为0.948(0.923~0.973)、0.858(0.728~0.987);在训练集中,列线图模型3、5和10 a生存率预测的AUC(95%CI)分别为0.966(0.946~0.986)、0.960(0.930~0.990)、0.934(0.906~0.962),在外部验证集中分别为0.825(0.769~0.881)、0.843(0.781~0.905)、0.868(0.796~0.940);校准曲线与标准曲线重合度较高,同时DCA显示模型具有理想的临床收益。结论:构建的列线图可用于婴幼儿RB生存率的预测,为临床个性化诊疗提供参考。 展开更多
关键词 视网膜母细胞瘤 婴幼儿 预后预测 列线图
下载PDF
人工智能技术在视网膜母细胞瘤中的应用现状
14
作者 袁路 杨卫华 陆斌 《国际眼科杂志》 CAS 2024年第5期758-761,共4页
视网膜母细胞瘤是一种常见于儿童的眼部恶性肿瘤,是威胁儿童视力和生命的主要原因之一。视网膜母细胞瘤的诊断和评估一直是临床的热点问题。在过去的几年,人工智能(AI)技术的应用在医学领域取得了显著进展,为视网膜母细胞瘤的诊断和治... 视网膜母细胞瘤是一种常见于儿童的眼部恶性肿瘤,是威胁儿童视力和生命的主要原因之一。视网膜母细胞瘤的诊断和评估一直是临床的热点问题。在过去的几年,人工智能(AI)技术的应用在医学领域取得了显著进展,为视网膜母细胞瘤的诊断和治疗提供了新的机会和挑战,如利用AI算法分析海量临床数据,可以帮助医生更准确地诊断疾病,提供个性化的治疗方案。此外,AI技术还在医学图像分析、基因组学研究等多方面发挥重要作用,可以助力新药开发、改善患者预后。本文结合近年研究情况,综述AI在视网膜母细胞瘤中的应用进展。 展开更多
关键词 人工智能 视网膜母细胞瘤 疾病诊断 医学图像分析 深度学习 辅助诊断
下载PDF
miRNA-106a在人淋巴瘤Jurkat细胞中的表达及作用机制
15
作者 唐国英 朱秀丽 +4 位作者 曲凡 戴若恒 李美楠 郑钰 刁玉巧 《癌症进展》 2024年第3期274-278,290,共6页
目的探讨miRNA-106a在人淋巴瘤Jurkat细胞中的表达及作用机制。方法取对数生长期人淋巴瘤Jurkat细胞,分别向培养基中加入5 ml生理盐水配制的浓度为0、0.5、1.0、1.5μg/ml的多柔比星,取健康体检者(对照组)的单个核细胞。采用定量逆转录... 目的探讨miRNA-106a在人淋巴瘤Jurkat细胞中的表达及作用机制。方法取对数生长期人淋巴瘤Jurkat细胞,分别向培养基中加入5 ml生理盐水配制的浓度为0、0.5、1.0、1.5μg/ml的多柔比星,取健康体检者(对照组)的单个核细胞。采用定量逆转录聚合酶链反应(qRT-PCR)检测miRNA-106a以及视网膜母细胞瘤1(RB1)、E2F转录因子1(E2F1)、胱天蛋白酶3(caspase 3)mRNA的表达水平,采用噻唑蓝(MTT)法检测细胞增殖能力,流式细胞术检测细胞凋亡能力,采用蛋白质印迹法(Western blot)检测RB1、E2F1、caspase 3蛋白的表达水平。结果0μg/ml多柔比星干预人淋巴瘤Jurkat细胞miRNA-106a的表达水平明显高于对照组单个核细胞(P﹤0.01)。随多柔比星浓度升高、作用时间延长,miRNA-106a表达水平逐渐降低,光密度(OD)值逐渐降低,细胞增殖抑制率(IR)和凋亡率均逐渐升高,RB1、caspase 3 mRNA及其蛋白的表达水平均逐渐升高,E2F1 mRNA及其蛋白的表达水平均逐渐降低,差异均有统计学意义(P﹤0.05)。相关性分析结果显示,miRNA-106a与RB1、caspase 3的表达均呈负相关(P﹤0.01),与E2F1的表达呈正相关(P﹤0.01)。结论miRNA-106a在人淋巴瘤Jurkat细胞中高表达,其可能通过调控RB/E2F1通路相关蛋白的表达来调节淋巴瘤进展。 展开更多
关键词 淋巴瘤 miRNA-106a 人淋巴瘤Jurkat细胞 视网膜母细胞瘤1 E2F转录因子1
下载PDF
动脉介入化疗“超选择法”与“球囊阻断法”治疗视网膜母细胞瘤的效果比较
16
作者 胡靖 王菲 +2 位作者 张景岚 刘景 时胜利 《河南医学研究》 CAS 2024年第16期2947-2950,共4页
目的观察动脉介入化疗“超选择法”与“球囊阻断法”治疗视网膜母细胞瘤(RB)的有效性、安全性。方法选取郑州大学附属儿童医院2020年6月至2022年6月收治的90例(141眼)RB患者作为研究对象,根据治疗方法分为超选组(45例,68眼)、阻断组(45... 目的观察动脉介入化疗“超选择法”与“球囊阻断法”治疗视网膜母细胞瘤(RB)的有效性、安全性。方法选取郑州大学附属儿童医院2020年6月至2022年6月收治的90例(141眼)RB患者作为研究对象,根据治疗方法分为超选组(45例,68眼)、阻断组(45例,73眼),给予超选组动脉介入化疗“超选择法”,给予阻断组动脉介入化疗“球囊阻断法”。比较两组临床疗效、血清肿瘤指标[存活素、Livin、血管内皮生长因子(VECF)、基质金属蛋白酶-9(MMP-9)]、保眼率、复发率、转移率、安全性分析及预后。结果超选组总有效率(95.59%)较阻断组(83.56%)高(P<0.05);治疗2、4个周期后超选组血清存活素、Livin、VEGE、MMP-9水平低于阻断组(P<0.05);两组保眼率、复发率、转移率、毒副反应及并发症、预后比较,差异无统计学意义(P>0.05)。结论动脉介入化疗“超选择法”与“球囊阻断法”治疗RB患儿的效果确切,但“超选择法”治疗效果优于“球囊阻断法”,两组安全性分析无明显差异。 展开更多
关键词 动脉介入化疗 超选择法 球囊阻断法 视网膜母细胞瘤 有效性 安全性
下载PDF
视网膜母细胞瘤患儿血清LncRNA-NEAT1水平表达及对瘤细胞生物学功能的影响
17
作者 罗文 罗钢 +4 位作者 周玉玲 胡佩宏 张青林 王莎莎 明媚 《现代检验医学杂志》 CAS 2024年第3期115-119,151,共6页
目的探讨长链非编码RNA(long non-coding RNA,LncRNA)核富集转录体1(nuclera-enriched autosomaltranscript,NEAT1)在视网膜母细胞瘤(retinoblastoma,Rb)患儿血清中表达,以及下调Rb细胞Y79中NEAT1对细胞生物学功能的影响。方法以2015年3... 目的探讨长链非编码RNA(long non-coding RNA,LncRNA)核富集转录体1(nuclera-enriched autosomaltranscript,NEAT1)在视网膜母细胞瘤(retinoblastoma,Rb)患儿血清中表达,以及下调Rb细胞Y79中NEAT1对细胞生物学功能的影响。方法以2015年3月~2021年3月鄂东医疗集团黄石市中心医院诊疗的83例Rb患儿为研究对象,同期,在儿童保健中心选取健康儿童50例(对照组),实时荧光定量PCR(quantitative real-time PCR,qRT-PCR)检测血清中NEAT1表达,分析Rb患儿和对照组血清NEAT1表达差异,以及不同临床指标Rb患者血清中NEAT1表达差异。培养Y79细胞并分为si-NEAT1组(转染NEAT1的干扰序列)、si-NC组(转染对照序列)和Ctl组(仅加入转染试剂),分别使用qRT-PCR,MTT,流式细胞术和Transwell检测NEAT1表达、细胞增殖、凋亡、迁移和侵袭情况。结果Rb患儿血清中NEAT1表达量(1.43±0.28)高于对照组(1.01±0.21),差异具有统计学意义(t=9.116,P<0.001);国际视网膜母细胞瘤分期(Intraocular International Retinoblastoma classificaton,IIRC)CDE期、低分化、视神经浸润和淋巴结转移的Rb患儿血清中NEAT1表达量明显高于AB期、中高分化、未发生视神经浸润和淋巴结转移的Rb患儿,差异具有统计学意义(t=2.190~3.693,均P<0.05);血清中NEAT1表达诊断Rb曲线下面积为0.882(95%CI:0.826~0.937),当NEAT1表达量取1.20时,灵敏度和特异度分别为80.00%和79.52%;相比于si-NC组(1.03±0.09)和Ctl组(1.02±0.15),si-NEAT1组细胞中NEAT1表达(0.35±0.06)明显降低,差异具有统计学意义(t=14.829,9.994,均P<0.001);si-NEAT1组24,48,72和96 h时吸光度(A值)明显低于si-NC组和Ctl组(tsi-NC=2.796~4.362,tCtl=2.641~5.555,均P<0.05),而细胞凋亡率相比于si-NC组和Ctl组明显升高,差异具有统计学意义(t=4.999,3.915,均P<0.05);与si-NC组和Ctl组比较,si-NEAT1组迁移细胞数(116.50±9.35 vs 132.00±7.32,134.00±7.95)和侵袭细胞数(96.33±8.94 vs 117.67±12.39,119.17±10.05)均降低,差异具有统计学意义(tsi-NC=3.196,3.421,tCtl=3.492,4.159,均P<0.05)。结论Rb患儿血清中NEAT1表达量升高,对Rb患儿具有一定的诊断价值,沉默Y79细胞中NEAT1表达可减少Rb细胞增殖、加速细胞凋亡,同时抑制细胞迁移和侵袭。 展开更多
关键词 视网膜母细胞瘤 长链非编码RNA 核富集转录体1 细胞增殖 细胞生物学特性
下载PDF
清代医家梁廉夫辨治小儿痘证经验探析
18
作者 李明庚 戴铭 《中国中医急症》 2024年第5期899-901,共3页
清代医家梁廉夫在辨治小儿痘证方面有其独到之处。梁氏认为小儿痘证乃体内胎毒受时邪侵入触动而发;辨治时强调需辨痘与伤寒之别,辨气病血病,辨表里寒热。在治疗痘证方面,提出了三宜三忌:宜细察虚实,忌妄投医药;宜益气补血,忌克伐气血;... 清代医家梁廉夫在辨治小儿痘证方面有其独到之处。梁氏认为小儿痘证乃体内胎毒受时邪侵入触动而发;辨治时强调需辨痘与伤寒之别,辨气病血病,辨表里寒热。在治疗痘证方面,提出了三宜三忌:宜细察虚实,忌妄投医药;宜益气补血,忌克伐气血;宜健脾益肾,忌清热败毒。本文通过研究其著作《不知医必要》,浅析梁氏辨治小儿痘证的学术经验,以期为现代临床诊疗提供参考。 展开更多
关键词 小儿痘证 《不知医必要》 梁廉夫 辨治经验
下载PDF
血清LncRNA NEAT1、TFF1在视网膜母细胞瘤中的表达及预后评估价值
19
作者 万宇 邹云春 +3 位作者 王岚 李娜 何艺岚 王淑 《疑难病杂志》 CAS 2024年第8期987-992,共6页
目的分析视网膜母细胞瘤(Rb)患儿血清长链非编码RNA核内富集转录物1(LncRNA NEAT1)、三叶因子1(TFF1)表达及预后评估价值。方法选取2018年1月—2021年1月首都医科大学附属北京安贞医院南充医院眼科手术治疗的Rb患儿85例作为Rb组,以同期... 目的分析视网膜母细胞瘤(Rb)患儿血清长链非编码RNA核内富集转录物1(LncRNA NEAT1)、三叶因子1(TFF1)表达及预后评估价值。方法选取2018年1月—2021年1月首都医科大学附属北京安贞医院南充医院眼科手术治疗的Rb患儿85例作为Rb组,以同期体检健康者60例为健康对照组。采用实时荧光定量PCR检测血清LncRNA NEAT1水平,采用酶联免疫吸附试验检测血清TFF1;分析血清LncRNA NEAT1、TFF1与临床病理特征的关系;Cox回归分析Rb预后影响因素;受试者工作特征(ROC)曲线分析血清LncRNA NEAT1、TFF1对Rb患儿预后的评估价值。结果Rb组血清LncRNA NEAT1水平高于健康对照组,血清TFF1低于健康对照组(t/P=38.305/<0.001、34.858/<0.001)。与肿瘤直径<20 mm、病理分化型Rb患儿比较,肿瘤直径≥20 mm、未分化型Rb患儿血清LncRNA NEAT1较高,TFF1较低(LncRNA NEAT1:t/P=17.925/<0.001,16.848/<0.001;TFF1:t/P=12.505/<0.001,8.120/<0.001)。血清LncRNA NEAT1高表达组3年无进展生存率低于低表达组(57.50%vs.88.89%),TFF1低表达组3年无进展生存率低于高表达组(57.14%vs.90.70%)(Log rankχ^(2)/P=13.551/<0.001、15.310/<0.001)。病理未分化型、血清LncRNA NEAT1升高是影响Rb预后的危险因素,血清TFF1升高是其保护因素[HR(95%CI)=1.523(1.147~2.024),1.473(1.108~1.957),0.612(0.413~0.908)];血清LncRNA NEAT1、TFF1及二者联合预测Rb预后的曲线下面积分别为0.836、0.861、0.921,二者联合大于血清LncRNA NEAT1、TFF1单项检测(Z=4.823、4.312,P均<0.001)。结论Rb患儿血清LncRNA NEAT1升高,血清TFF1水平降低,两者与肿瘤最大径及病理分型有关,均是影响Rb患儿预后的因素,两者联合有助于评估患者预后。 展开更多
关键词 视网膜母细胞瘤 长链非编码RNA核内富集转录物1 三叶因子1 预后预测 儿童
下载PDF
超声造影联合中国甲状腺影像报告和数据系统在甲状腺结节诊断和活检效能中的研究
20
作者 阳玉晶 杨红 +1 位作者 文荣 高瑞智 《中国当代医药》 2024年第1期81-84,共4页
目的探讨中国甲状腺影像报告和数据系统(C-TIRADS)联合超声造影在诊断甲状腺结节的价值。方法选取2022年1月至6月在广西医科大学第一附属医院超声科接受超声检查的413例甲状腺结节患者(413个结节)作为研究对象,以病理学检查结果为“金... 目的探讨中国甲状腺影像报告和数据系统(C-TIRADS)联合超声造影在诊断甲状腺结节的价值。方法选取2022年1月至6月在广西医科大学第一附属医院超声科接受超声检查的413例甲状腺结节患者(413个结节)作为研究对象,以病理学检查结果为“金标准”,所有患者均进行C-TIRADS分类及其联合超声造影检查。比较C-TIRADS分类、C-TIRADS分类联合超声造影检查的灵敏度、特异度及准确度;并分别根据C-TIRADS指南和C-TIRADS指南联合超声造影进行推荐甲状腺活检,分别计算并比较两种方法的恶性肿瘤的活检产量、恶性肿瘤的活检率以及不必要的活检率。结果C-TIRADS检查结果诊断良性结节363例,恶性结节50例;C-TIRADS联合超声造影检查结果诊断良性结节267例,恶性结节146例。C-TIRADS联合超声造影检查的诊断甲状腺癌的灵敏度、特异度、准确度均高于应用C-TIRADS检查,差异有统计学意义(P<0.05)。所有结节、1.0~1.5cm结节中,C-TIRADS联合超声造影的恶性肿瘤活检率低于C-TIRADS单独分类,>1.5cm结节中,C-TIRADS联合超声造影的恶性肿瘤活检率、不必要活检率均低于C-TIRADS单独分类,差异有统计学意义(P<0.05)。结论C-TIRADS与超声造影相联合可提高甲状腺结节的超声诊断效能,并且将超声造影联合C-TIRADS去推荐甲状腺活检也能提高推荐甲状腺结节活检的可靠性,在增加恶性结节的活检产率的同时还能减少甲状腺良性结节的不必要活检率。 展开更多
关键词 甲状腺结节 中国甲状腺影像报告和数据系统 超声造影 诊断效能 不必要活检率
下载PDF
上一页 1 2 114 下一页 到第
使用帮助 返回顶部